Ameriprise
SMTI icon

Ameriprise’s Sanara MedTech SMTI Stock Holding History

Ameriprise’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,152
Closed -$371K – 4008
2024
Q2 		$371K Sell
13,152
-2,441
-16% -$76.6K ﹤0.01% 3524
2024
Q1 		$577K Sell
15,593
-437
-3% -$16.3K ﹤0.01% 3368
2023
Q4 		$659K Sell
16,030
-2,437
-13% -$78.2K ﹤0.01% 3354
2023
Q3 		$575K Sell
18,467
-164
-0.9% -$6.35K ﹤0.01% 3354
2023
Q2 		$747K Buy
18,631
+899
+5% +$36.8K ﹤0.01% 3287
2023
Q1 		$731K Buy
17,732
+3,886
+28% +$164K ﹤0.01% 3284
2022
Q4 		$629K Buy
+13,846
New +$477K ﹤0.01% 3320

Other funds holding SMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise's SMTI Position: Q3 2024 in Review

Ameriprise sold out of Sanara MedTech (SMTI) in Q3 2024, closing a stake of 13,152 shares — an estimated $371K sold.

Ameriprise first reported a position in SMTI in Q4 2022 and held it in 7 quarters. The position peaked at $747K in Q2 2023. 44 funds tracked by Wall St. Rank hold SMTI as of Q3 2024.

  • Ameriprise reported no remaining Sanara MedTech position as of Q3 2024 after selling out during the quarter.
  • Ameriprise sold 13,152 Sanara MedTech shares in Q3 2024, an estimated $371K.
  • Ameriprise first reported a position in Sanara MedTech in Q4 2022 and held it in 7 quarters.
  • Ameriprise's Sanara MedTech position peaked at $747K in Q2 2023.
  • 44 funds tracked by Wall St. Rank held Sanara MedTech as of Q3 2024.

Based on Ameriprise's 13F filing for Q3 2024, filed 14 Nov 2024.